tiprankstipranks
Advertisement
Advertisement

HK:2627 Stock Latest News

Ab&B Bio-Tech Faces Delisting Risk as Hong Kong Sets Strict Resumption Terms
Company AnnouncementsAb&B Bio-Tech Faces Delisting Risk as Hong Kong Sets Strict Resumption Terms
7d ago
2627
Ab&B Bio-Tech Taps Prism Hong Kong as New Auditor After Deloitte Exit
PremiumCompany Announcements
Ab&B Bio-Tech Taps Prism Hong Kong as New Auditor After Deloitte Exit
12d ago
2627
Ab&B Bio-Tech Strengthens Board With New Independent Director Nomination
PremiumCompany Announcements
Ab&B Bio-Tech Strengthens Board With New Independent Director Nomination
12d ago
2627
Ab&B Bio-Tech Details Board Composition and Committee Roles
PremiumCompany Announcements
Ab&B Bio-Tech Details Board Composition and Committee Roles
17d ago
2627
Ab&B Bio-Tech to Scrap Supervisory Committee and Revamp Governance Framework
PremiumCompany Announcements
Ab&B Bio-Tech to Scrap Supervisory Committee and Revamp Governance Framework
17d ago
2627
Ab&B Bio-Tech Auditor Resigns Amid Probe Into Fund Investments and Consultancy Payments
PremiumCompany AnnouncementsAb&B Bio-Tech Auditor Resigns Amid Probe Into Fund Investments and Consultancy Payments
22d ago
2627
Ab&B Bio-Tech Delays 2025 Results, Triggers Trading Suspension in Hong Kong
Premium
Company Announcements
Ab&B Bio-Tech Delays 2025 Results, Triggers Trading Suspension in Hong Kong
1M ago
2627
Ab&B Bio-Tech Sets Board Meeting to Approve 2025 Results and Weigh Final Dividend
Premium
Company Announcements
Ab&B Bio-Tech Sets Board Meeting to Approve 2025 Results and Weigh Final Dividend
2M ago
2627
Ab&B Bio-Tech Partners with Walvax Unit to Take Flu Vaccine Overseas
PremiumCompany Announcements
Ab&B Bio-Tech Partners with Walvax Unit to Take Flu Vaccine Overseas
2M ago
2627
Ab&B Bio-Tech Wins U.S. FDA IND Nod for mRNA Mpox Vaccine, Bolstering Global Vaccine Ambitions
PremiumCompany Announcements
Ab&B Bio-Tech Wins U.S. FDA IND Nod for mRNA Mpox Vaccine, Bolstering Global Vaccine Ambitions
2M ago
2627
Ab&B Bio-Tech Forecasts Strong Revenue Growth and Narrowing Loss for 2025
PremiumCompany Announcements
Ab&B Bio-Tech Forecasts Strong Revenue Growth and Narrowing Loss for 2025
2M ago
2627
Ab&B Bio-Tech Added to Hang Seng Composite Index, Boosting Market Profile
PremiumCompany Announcements
Ab&B Bio-Tech Added to Hang Seng Composite Index, Boosting Market Profile
3M ago
2627
Ab&B Bio-Tech Wins NMPA Approval for First All-Ages Trivalent Subunit Flu Vaccine in China
PremiumCompany AnnouncementsAb&B Bio-Tech Wins NMPA Approval for First All-Ages Trivalent Subunit Flu Vaccine in China
3M ago
2627
Ab&B Bio-Tech Announces Board and Company Secretary Resignations
Premium
Company Announcements
Ab&B Bio-Tech Announces Board and Company Secretary Resignations
4M ago
2627
Ab&B Bio-Tech Shareholders Unanimously Back New INED and Auditor Reappointment
Premium
Company Announcements
Ab&B Bio-Tech Shareholders Unanimously Back New INED and Auditor Reappointment
4M ago
2627
Ab&B Bio-Tech Outlines Board Composition and Committee Roles
PremiumCompany Announcements
Ab&B Bio-Tech Outlines Board Composition and Committee Roles
4M ago
2627
Ab&B Bio-Tech Initiates Phase III Trials for Rabies Vaccine
PremiumCompany Announcements
Ab&B Bio-Tech Initiates Phase III Trials for Rabies Vaccine
5M ago
2627
Ab&B Bio-Tech Announces Board Changes with New Director Nomination
PremiumCompany Announcements
Ab&B Bio-Tech Announces Board Changes with New Director Nomination
5M ago
2627
Ab&B Bio-Tech CO., LTD. JS Announces 2025 Extraordinary General Meeting
PremiumCompany Announcements
Ab&B Bio-Tech CO., LTD. JS Announces 2025 Extraordinary General Meeting
5M ago
2627
Ab&B Bio-Tech Initiates Clinical Trials for Innovative Influenza Vaccines
PremiumCompany AnnouncementsAb&B Bio-Tech Initiates Clinical Trials for Innovative Influenza Vaccines
6M ago
2627
Ab&B Bio-Tech CO., LTD. Seeks Full Circulation of H Shares
Premium
Company Announcements
Ab&B Bio-Tech CO., LTD. Seeks Full Circulation of H Shares
7M ago
2627
Ab&B Bio-Tech’s Quadrivalent Influenza Vaccine Gains Approval in China
Premium
Company Announcements
Ab&B Bio-Tech’s Quadrivalent Influenza Vaccine Gains Approval in China
8M ago
2627

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >